Loading organizations...
Loading organizations...
Biotechnology company developing treatments for Hirschsprung disease.
Neurenati Therapeutics has raised $4.3M across 3 funding rounds.
Neurenati Therapeutics has raised $4.3M in total across 3 funding rounds.
Neurenati Therapeutics has raised $4.3M in total across 3 funding rounds.
Neurenati Therapeutics's investors include Quebec Government.
Neurenati Therapeutics has raised $4.3M across 3 funding rounds. Most recently, it raised $1.7M Seed Extension in March 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 4, 2025 | $1.7M Seed Extension | ||
| Apr 18, 2024 | $1.4M Other Equity | Quebec Government | |
| Feb 29, 2024 | $1.2M Seed |